Aldemar Montero

1.6k citations

18 papers · 1.1k indexed · h-index 11

Hematology top 2%
- Hematopoietic Stem Cell Transplantation 11
- Acute Myeloid Leukemia Research 3
- Chronic Myeloid Leukemia Treatments 3
Immunology top 5%
- Immune Cell Function and Interaction 4
- T-cell and B-cell Immunology 3
Transplantation top 10%
Oncology top 10%
- Polyomavirus and related diseases 3
Genetics top 10%
Pulmonary and Respiratory Medicine
- Advanced Breast Cancer Therapies 3
Surgery
- Transplantation: Methods and Outcomes 3

Co-authors: Bipin N. Savani Stephan Mielke Katayoun Rezvani Roger Kurlander Yosuke Okada J. Douglas Coffin Marja M. Hurley Thomas Doetschman
Cited by: Hematology Immunology Transplantation
Journals: Blood (6 papers)Biology of Blood and Marrow Transplantation (5 papers)Journal of Clinical Oncology (2 papers)
Partner nations: United States Malaysia Japan

In The Last Decade

Aldemar Montero

17 papers receiving 1.1k citations

Peers

Countries citing papers authored by Aldemar Montero

Since Specialization

Citations

This map shows the geographic impact of Aldemar Montero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aldemar Montero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aldemar Montero more than expected).

Fields of papers citing papers by Aldemar Montero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aldemar Montero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aldemar Montero. The network helps show where Aldemar Montero may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Aldemar Montero, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Aldemar Montero Line = papers co-authored together Aldemar Montero links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work
1	Real-world quality of life (QoL) in black, indigenous and people of color (BIPOC) treated with palbociclib (PAL) and endocrine therapy for hormone receptor–positive (HR+)/human epidermal growth factor receptor 2–negative (HER2–) advanced breast cancer (ABC): A subgroup analysis from POLARIS. Journal of Clinical Oncology ·Gabrielle B. Rocque,Joanne L. Blum,Aldemar Montero,Meghan Karuturi,Alexander Ussim,Kenneth Mallin,Christopher Gallagher,Ana Cíntia Brandão dos Santos,Joseph C. Cappelleri,骆仲泱 LUO Zhong-yang,Yao Wang,Debu Tripathy	2021	1
2	Abstract PD10-03: Quality of life in patients with hormone receptor-positive/human epidermal growth factor receptor 2-negative advanced breast cancer treated with palbociclib in real-world practice settings Cancer Research ·Gabrielle B. Rocque,Joanne L. Blum,Aldemar Montero,Ciro Rafael Eraso,Sobha Kurian,Richard C. Frank,Sajjad Rahimi,Mayank Ajmera,David Coblentz,Joseph C. Cappelleri,Yao Wang,Debu Tripathy	2020	3
3	Understanding palbociclib practice patterns in a real-world setting. Journal of Clinical Oncology ·Gabrielle B. Rocque,Joanne L. Blum,Aldemar Montero,Sharon Wilks,D. Mark Anderson,Mohamad A. Salkeni,Sami Diab,Rui Gonçalves,Ciro Rafael Eraso,N. Sharmila Devi,Bethany Sleckman,Joseph C. Cappelleri,Yao Wang,Debu Tripathy	2019	1
4	A Pilot Study Of Rituximab In Patients With Moderate Aplastic Anemia, Diamond-Blackfan Anemia and Pure Red Cell Aplasia Blood ·Sabrina Martyr,S. O. Addy,Aldemar Montero,Cynthia E. Dunbar,Elizabeth M. Kang,Phillip Scheinberg,Barbara Weinstein,Xin Tian,Neal S. Young,Adrian Wiestner	2013	2
5	Managing Chronic Myeloid Leukemia: A Coordinated Team Care Perspective Clinical Lymphoma Myeloma & Leukemia ·Baoshan CHEN,E. Mystkowski,Minnie Strickland,James M. Bono,Alison Place,Morgan L. McLemore,Ermilov AIu,Aldemar Montero,李庆荣,Gitte Stentebjerg Petersen,Arini Yuliana,Silpa C. Reddy,Angie Barbieri María,Leonard T. Heffner,Elliott F. Winton,Martha Arellano,H. Jean Khoury	2011	12
6	Absolute Lymphocyte Count on Day 30 Is a Surrogate for Robust Hematopoietic Recovery and Strongly Predicts Outcome after T Cell-Depleted Allogeneic Stem Cell Transplantation Biology of Blood and Marrow Transplantation ·Bipin N. Savani,Stephan Mielke,Katayoun Rezvani,Aldemar Montero,Agnes S. M. Yong,Nindytia Puspitasari Dalimunthe,Sindy Dorely Prieto-Pulido,Roger Kurlander,Anurag K. Singh,Richard Childs,A. John Barrett	2007	96
7	T Cell Depleted Peripheral Blood Stem Cell Allotransplantation with T Cell Add Back for Patients with Hematological Malignancies: Effect of Chronic GVHD on Outcome Biology of Blood and Marrow Transplantation ·Aldemar Montero,Bipin N. Savani,Aarthi Shenoy,Elizabeth J. Read,Charles S. Carter,Susan F. Leitman,Stephan Mielke,Katayoun Rezvani,Richard Childs,A. John Barrett	2006	38
8	Chronic GVHD and Pretransplantation Abnormalities in Pulmonary Function Are the Main Determinants Predicting Worsening Pulmonary Function in Long-term Survivors after Stem Cell Transplantation Biology of Blood and Marrow Transplantation ·Bipin N. Savani,Aldemar Montero,Ramaprasad Srinivasan,Anurag K. Singh,Aarthi Shenoy,Stephan Mielke,Katayoun Rezvani,Shervin Karimpour,Richard Childs,A. John Barrett	2006	43
9	High donor FOXP3-positive regulatory T-cell (Treg) content is associated with a low risk of GVHD following HLA-matched allogeneic SCT Blood ·Katayoun Rezvani,Stephan Mielke,Mojgan Ahmadzadeh,Yasemin Kilical,Bipin N. Savani,諭篠脇,Keyvan Keyvanfar,Aldemar Montero,Nancy F. Hensel,Roger Kurlander,A. John Barrett	2006	277
10	Improved Outcome for Peripheral Blood Stem Cell Transplantation for Advanced Primary Myelodysplastic Syndrome Biology of Blood and Marrow Transplantation ·Scott R. Solomon,Bipin N. Savani,Richard Childs,Aldemar Montero,Carol Boss,Elizabeth J. Read,Susan F. Leitman,A. John Barrett	2005	10
11	Prediction and prevention of transplant-related mortality from pulmonary causes after total body irradiation and allogeneic stem cell transplantation Biology of Blood and Marrow Transplantation ·Bipin N. Savani,Aldemar Montero,Colin O. Wu,Dawn C. Bradshaw,Elizabeth J. Read,Cynthia E. Dunbar,Richard Childs,Scott R. Solomon,A. John Barrett	2005	41
12	Lineage‐specific engraftment and outcomes after T‐cell‐depleted peripheral blood stem cell transplant with Flu/Cy/TBI conditioning British Journal of Haematology ·Aldemar Montero,Bipin N. Savani,Roger Kurlander,Elizabeth J. Read,Susan F. Leitman,Richard Childs,Scott R. Solomon,A. John Barrett	2005	12
13	Selective depletion of alloreactive donor lymphocytes: a novel method to reduce the severity of graft-versus-host disease in older patients undergoing matched sibling donor stem cell transplantation Blood ·Scott R. Solomon,Stephan Mielke,Bipin N. Savani,Aldemar Montero,Laura Wisch,Richard Childs,Nancy F. Hensel,John Schindler,Victor Gheţie,Susan F. Leitman,Lehnartz,Charles S. Carter,Roger Kurlander,Elizabeth J. Read,Ellen S. Vitetta,A. John Barrett	2005	109
14	Factors associated with early molecular remission after T cell-depleted allogeneic stem cell transplantation for chronic myelogenous leukemia Blood ·Bipin N. Savani,Katayoun Rezvani,Stephan Mielke,Aldemar Montero,Roger Kurlander,Charles S. Carter,Susan F. Leitman,Elizabeth J. Read,Richard Childs,A. John Barrett	2005	70
15	Prediction and Prevention of Transplant Related Mortality from Pulmonary Causes Following Total Body Irradiation and Allogeneic Stem Cell Transplantation. Blood ·Bipin N. Savani,Aldemar Montero,Y. Li,Dawn C. Bradshaw,Richard Childs,Scott R. Solomon,John Barrett	2004	1
16	Improved Outcomes for Peripheral Blood Stem Cell Transplantation in Advanced Myelodysplastic Syndrome. Blood ·Scott R. Solomon,Richard Childs,Aldemar Montero,Elaine M. Sloand,Laura Wisch,Leslie Wehrlen,John Barrett	2004	0
17	Impaired Osteoclast Formation in Bone Marrow Cultures of Fgf2 Null Mice in Response to Parathyroid Hormone Journal of Biological Chemistry ·Yosuke Okada,Aldemar Montero,Xuxia Zhang,Takanori Sobue,Joseph A. Lorenzo,Thomas Doetschman,J. Douglas Coffin,Marja M. Hurley	2003	41
18	Disruption of the fibroblast growth factor-2 gene results in decreased bone mass and bone formation Journal of Clinical Investigation ·Aldemar Montero,Yosuke Okada,Masato Tomita,Masako Ito,Hiroshi Tsurukami,Toshitaka Nakamura,Thomas Doetschman,J. Douglas Coffin,Marja M. Hurley	2000	373

About Aldemar Montero

Aldemar Montero is a scholar working on Hematology, Oncology and Cancer Research, having authored 18 papers that have together received 1.1k indexed citations. Recurring topics across this work include Hematopoietic Stem Cell Transplantation (11 papers), Immune Cell Function and Interaction (4 papers), Acute Myeloid Leukemia Research (3 papers), Advanced Breast Cancer Therapies (3 papers), Transplantation: Methods and Outcomes (3 papers), T-cell and B-cell Immunology (3 papers), Chronic Myeloid Leukemia Treatments (3 papers) and Polyomavirus and related diseases (3 papers). The work is most often cited by research in Hematology (552 citations), Immunology (451 citations) and Transplantation (37 citations). Aldemar Montero has collaborated with scholars based in United States, Malaysia and Japan. Frequent co-authors include Bipin N. Savani, Stephan Mielke, Katayoun Rezvani, Roger Kurlander, Yosuke Okada, J. Douglas Coffin, Marja M. Hurley, Thomas Doetschman, Toshitaka Nakamura and Masato Tomita. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, British Journal of Haematology and Journal of Biological Chemistry.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact